Melanotan II (10 mg Vial) Dosage Protocol

TOC with Icons
Table of Contents

Quickstart Highlights

Melanotan II is a synthetic analog of α-melanocyte-stimulating hormone studied for its ability to increase skin pigmentation and noted for inducing erectile activity as a side effect[1]. Early human trials identified effective daily doses in the range of 1–2 mg for tanning, with conservative protocols starting lower to minimize side effects such as nausea and flushing[2][3]. This educational protocol presents a once-daily subcutaneous titration approach using practical dilution for clear insulin-syringe measurements.

  • Reconstitute: Add 3.0 mL bacteriostatic water → 3.33 mg/mL concentration.
  • Typical daily range: 250–1000 mcg once daily (gradual titration over 8–12 weeks).
  • Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F) or below; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 1–2 weeks.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Titration (3 mL = 3.33 mg/mL)

Week

Daily Dose

Units (per injection) (mL)

Weeks 1

250 mcg (0.25 mg)

7.5 units (0.075 mL)

Weeks 2

500 mcg (0.5 mg)

15 units (0.15 mL)

Weeks 3

750 mcg (0.75 mg)

22.5 units (0.225 mL)

Week4-8

1000 mcg (1 mg)

30 units (0.30 mL)

Maintenance
(after Week 8)

500–1000 mcg
(1–2× weekly)

15–30 units
(0.15–0.30 mL)

Frequency: Inject once daily subcutaneously during the initial 8-week tanning phase; transition to 1–2 injections per week for maintenance dosing to sustain pigmentation[3]. This schedule uses the standard 3.0 mL dilution for consistent unit measurements. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall to avoid foaming; do not shake vigorously.
  3. Gently roll or swirl the vial until the powder is fully dissolved.
  4. Label the vial with the reconstitution date and store refrigerated at 2–8 °C (35.6–46.4 °F), protected from light.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Advanced / Aggressive Approach (3.0 mL = ~16.67 mg/mL)

Week

Daily Dose

Units (per injection) (mL)

Weeks 1–2

5 mg (5000 mcg)

30 units (0.30 mL)

Weeks 3–4

10 mg (10,000 mcg)

60 units (0.60 mL)

Weeks 5–8

15 mg (15,000 mcg)

90 units (0.90 mL)

Note: Advanced dosing (15–20 mg/day) is based on short‑term clinical trial protocols[4][5] for severe mitochondrial conditions and should only be pursued under medical supervision. At this concentration, doses up to 15 mg fit in a single syringe (90 units); 20 mg doses should be split into two separate subcutaneous injections at different sites. Clinical trials have not extensively evaluated SS‑31 beyond 12 weeks; extended use requires careful monitoring.

Important: This guide is for educational purposes only and is not medical advice.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration (including transition to maintenance dosing).

  • Peptide Vials (Melanotan II, 10 mg each):

     

    • 8 weeks ≈ 5 vials (~45–50 mg total)
    • 12 weeks ≈ 8 vials (~70–75 mg total)
    • 16 weeks ≈ 10 vials (~95–100 mg total)
  • Insulin Syringes (U-100, 1 mL):

     

    • Per week (daily dosing): 7 syringes
    • 8 weeks: 56 syringes
    • 12 weeks: 84 syringes
    • 16 weeks: 112 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

     

    • 8 weeks (5 vials): 15 mL → 2 × 10 mL bottles
    • 12 weeks (8 vials): 24 mL → 3 × 10 mL bottles
    • 16 weeks (10 vials): 30 mL → 3 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.

     

    • Per week: 14 swabs (2/day)
    • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
    • 12 weeks: 168 swabs → recommend 2 × 100-count boxes
    • 16 weeks: 224 swabs → recommend 3 × 100-count boxes

Protocol Overview

Concise summary of the once-daily subcutaneous regimen.

  • Goal: Increase skin pigmentation (tanning) through melanocortin receptor activation[1].
  • Schedule: Daily subcutaneous injections for 6–8 weeks during loading phase, then maintenance dosing 1–2× weekly[3].
  • Dose Range: 250–1000 mcg daily with gradual titration to minimize side effects.
  • Reconstitution: 3.0 mL per 10 mg vial (3.33 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F); use within 1–2 weeks[7].

Dosing Protocol

Suggested daily titration approach based on clinical research.

  • Start: 200–250 mcg daily; increase by 100–250 mcg increments every 1–2 weeks as tolerated[2].
  • Target: 500–1000 mcg daily by Weeks 4–8 (studied effective range is 1–2 mg/day)[1].
  • Frequency: Once per day (subcutaneous) during loading phase.
  • Cycle Length: 6–8 weeks for initial tanning, then switch to maintenance dosing.
  • Maintenance: 500–1000 mcg administered 1–2× per week to sustain pigmentation[3].
  • Timing: Any consistent time; rotate injection sites to reduce irritation.

Storage Instructions

Proper storage preserves peptide stability and potency.

  • Lyophilized: Store at −20 °C (−4 °F) or below in dry, dark conditions; keep desiccated to minimize moisture exposure[7].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 1–2 weeks with bacteriostatic water preservative[7].
  • Avoid freeze–thaw: Do not refreeze reconstituted solution; prepare aliquots if longer storage needed.
  • Allow vials to reach room temperature before opening to reduce condensation.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each injection; dispose in a sharps container immediately[9].
  • Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and scarring[10].
  • Clean vial stopper and injection site with alcohol swabs before each use; allow to air dry[11].
  • Inject slowly and steadily; wait a few seconds before withdrawing the needle.
  • Document daily dose, injection site, and any side effects to maintain consistency and track tolerance.
  • Safety warning: Do not exceed 2 mg per day; case reports document serious systemic toxicity and rhabdomyolysis at mega-doses (6 mg)[4].

How This Works

Melanotan II is a synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone that binds to melanocortin receptors, particularly MC1R and MC4R[1]. Activation of MC1R on melanocytes stimulates melanin production and distribution, resulting in increased skin pigmentation even without UV exposure[2]. Early Phase I studies in humans identified 0.025 mg/kg per day (approximately 1.5–2 mg for an average adult) as an appropriate dose, with measurable tanning observed after just five low doses administered over two weeks[1]. The peptide’s subcutaneous administration allows for steady melanocortin receptor activation, with effects accumulating over the course of daily injections during the initial tanning phase[3].

Potential Benefits & Side Effects

Observations from clinical trials and case reports.

Potential Benefits

  • Increases skin pigmentation (tanning) without UV exposure requirement[1][2].
  • Tanning effects observable after 5–10 daily injections in most individuals[1].
  • May induce spontaneous erections in men as a noted side effect (MC4R activation)[3][5].
  • Maintenance dosing (1–2× weekly) can sustain pigmentation after initial loading phase[3].

Common Side Effects

  • Nausea (dose-dependent; most common at higher doses)[1][2].
  • Facial flushing and increased skin warmth[3].
  • Reduced appetite and mild fatigue[1].
  • Spontaneous erections or increased libido in men[5].
  • Injection site reactions (redness, mild stinging)[9].

Serious Risks & Warnings

  • Not FDA-approved: Melanotan II is not an approved medication; use carries regulatory and safety risks[6].
  • Dose-limiting toxicity: Severe sympathomimetic symptoms and rhabdomyolysis reported at 6 mg dose[4].
  • Mole changes: May alter pigmentation of existing moles; theoretical melanoma concerns warrant caution[6].
  • Cardiovascular effects: Transient increases in heart rate and blood pressure possible at higher doses[3].

Lifestyle Factors

Complementary strategies for safe and effective outcomes.

  • UV exposure: Melanotan II increases melanin without UV, but some users combine with minimal UV exposure; always use appropriate sun protection to reduce skin cancer risk[6].
  • Hydration: Maintain adequate fluid intake, especially if experiencing nausea or appetite suppression.
  • Monitoring: Inspect moles and skin regularly for changes; seek dermatological evaluation if new or changing lesions appear[6].
  • Dose discipline: Adhere strictly to conservative dosing protocols; never exceed 2 mg per day to avoid serious adverse effects[4].

Injection Technique

Subcutaneous injection guidance from clinical best-practice resources[9][11].

  • Clean the vial stopper and injection site with alcohol swabs; allow both to air dry completely[11].
  • Use a 1 mL insulin syringe (29–31 gauge, ½ inch needle) for subcutaneous administration[9].
  • Pinch a fold of skin approximately 1 inch thick at the injection site (abdomen preferred, at least 2 inches from navel)[10].
  • Insert the needle at 45–90° depending on body composition; release the pinch after needle insertion[10].
  • Do not aspirate for subcutaneous injections; inject slowly and steadily[11].
  • Withdraw the needle at the same angle; apply gentle pressure with clean gauze if needed.
  • Rotate sites systematically to avoid lipohypertrophy or scarring[10].
  • Dispose of used syringes immediately in a proper sharps container; never reuse needles[9].

Recommended Source

We recommend Pure Lab Peptides for high-purity Melanotan II (10 mg).

Why Pure Lab Peptides?

  • High-purity, third-party-tested lots with batch certificates of analysis (COAs).
  • Consistent, ISO-aligned handling and quality documentation.
  • Reliable fulfillment with proper cold-chain shipping to maintain peptide integrity.